News
Matt Burton was issued with a one-match ban ... charge at the NRL Judiciary and will miss three matches. Latrell Mitchell copped a one-match ban for a high shot during his side's loss to ...
Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended March 2025. While this widely-known consensus outlook ...
Matthew Mitchell is a senior fellow in the Center for Human Freedom at the Fraser Institute and a senior affiliated scholar with the Mercatus Center at George Mason University. April 27 ...
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...
Clearly, options traders are pricing in a big move for Globus Medical shares, but what is the fundamental picture for the company? Currently, Globus Medical is a Zacks Rank #3 (Hold) in the ...
Matt Mitchell is a pianist and composer interested in the intersections of various strains of acoustic, electric, composed, and improvised new music. He currently composes for and leads several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results